Simsen Diagnostics
PrivateLast Round
Early Funding
May 5, 2026
Total Funding Raised
$1.41M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Simsen Diagnostics operates in Healthcare & Life Sciences and is based in Mölndal. Its latest recorded funding round was an Early Funding round in May 2026.
Simsen Diagnostics is a healthcare technology company that specializes in ultra-sensitive, personalized blood tests that detect and monitor cancer by analyzing circulating tumor DNA (ctDNA).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simsen Diagnostics Comparables
Compare Simsen Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Natera, Inc. | 79% | |
| NeoGenomics Inc | 78% | |
| Personalis Inc | 78% |
For institutional investors. Book with your work email.
Simsen Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 5, 2026 | ||||
| Grant | Apr 23, 2024 | ||||
| Grant | Nov 9, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Simsen Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Swedish Research Council for Sustainable Development (Formas) | Grant |
| Vasa Angels I | Early Funding |
| Vinnova | Grant |
| J.F.B Invest | Early Funding |
| Swelife | Grant |
| Nordic Ignite | Early Funding |
| Gobia Enterprises | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 54% MoM.
- May 5, 2026
$1.08M raised, led by Gobia Enterprises.
For institutional investors. Book with your work email.
Simsen Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Simsen Diagnostics's valuation, stock price, and market status.
Is Simsen Diagnostics a public or private company?
Simsen Diagnostics is a private company.
What is the current stock price of Simsen Diagnostics?
Simsen Diagnostics is a private company, so its shares have no public market price. Caplight tracks Simsen Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Simsen Diagnostics worth (valuation)?
Valuation information for Simsen Diagnostics is not publicly available.
Can I buy Simsen Diagnostics stock?
Simsen Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Simsen Diagnostics's last funding round?
Simsen Diagnostics's most recent funding round was Early Funding on May 5, 2026.
Who are the main investors in Simsen Diagnostics?
Key investors in Simsen Diagnostics include Gobia Enterprises.
Will Simsen Diagnostics IPO soon?
No public IPO plans have been announced for Simsen Diagnostics.
How can I track Simsen Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Simsen Diagnostics's shares on secondary markets.